Arteris (AIP) Files Form 144 for 5.6K Share Rule 10b5-1 Sale

Rhea-AI Filing Summary

Arteris, Inc. (AIP) – Form 144 insider sale notice

Senior insider Nicholas Hawkins filed a Form 144 indicating an intent to sell 5,638 common shares of Arteris on 26-27 June 2025 through Morgan Stanley Smith Barney. Based on the stated price, the shares carry an aggregate market value of $54,012.04. With 41,977,728 shares outstanding, the proposed sale represents roughly 0.013 % of the company’s equity, a de-minimis portion of the float.

The shares were originally acquired on 19 December 2019 via the cash exercise of stock options. The filing states the sale will occur under a Rule 10b5-1 trading plan, signalling the trades were pre-arranged and not based on undisclosed information.

Recent insider activity: The same insider has executed several sales over the past three months, amounting to 37,772 shares for approximately $302,155 in gross proceeds. Transaction sizes ranged from 438 to 11,000 shares per trade.

While insider sales do not automatically imply negative prospects, some investors monitor the frequency of such transactions. The currently disclosed sale remains immaterial relative to Arteris’ share count and does not on its own alter the investment thesis.

Positive

• None.

Negative

• Continued insider selling: Hawkins has disposed of 37,772 shares over the past three months, which some investors may interpret as a mildly negative sentiment signal, albeit immaterial in size.

Insights

Financial Analyst

TL;DR – Small, pre-planned insider sale; neutral impact on AIP.

Form 144 shows Nicholas Hawkins may sell 5,638 Arteris shares (~$54k). Combined with prior 3-month activity, he has sold ~37.8k shares (~$302k). Even aggregated, this equals <0.1 % of shares outstanding, suggesting limited supply pressure. Because the trades fall under a Rule 10b5-1 plan, signaling pre-scheduled execution, I view the filing as routine. No operational, earnings, or strategic data is provided, so valuation fundamentals remain unchanged. Investors typically discount such modest, programmatic sales; therefore I assign a neutral materiality rating.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5638	54012.04	41977728	06/27/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/19/2019	Previously Exercised Stock Options	Issuer			5638	12/19/2019	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales Plan for NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	06/26/2025	5638	54970.50
10b5-1 Sales Plan for NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	06/25/2025	5638	53561.00
10b5-1 Sales Plan for NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	06/09/2025	3770	30405.45
10b5-1 Sales Plan for NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	06/05/2025	721	5521.06
10b5-1 Sales Plan for NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	06/04/2025	1730	13877.18
NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	06/02/2025	438	3374.05
10b5-1 Sales Plan for NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	05/08/2025	11000	82946.05
10b5-1 Sales Plan for NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	04/04/2025	4949	29822.67
NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	04/02/2025	3888	27677.12

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Arteris (AIP) shares are covered by the new Form 144 filing?

5,638 common shares are proposed for sale.

What is the aggregate market value of the shares to be sold?

The filing lists an aggregate value of $54,012.04.

When is the planned sale date for the 5,638 shares?

The shares are expected to be sold on 26-27 June 2025.

How many Arteris shares are outstanding according to the filing?

There are 41,977,728 shares outstanding.

What total volume has Nicholas Hawkins sold in the past three months?

He sold approximately 37,772 shares for about $302,155 in gross proceeds.

Is the planned sale under a Rule 10b5-1 trading plan?

Yes. The filing notes reliance on a Rule 10b5-1 plan.